NZ591613A - Polymorphic marker rs965513 for risk assessment of thyroid cancer - Google Patents
Polymorphic marker rs965513 for risk assessment of thyroid cancerInfo
- Publication number
- NZ591613A NZ591613A NZ591613A NZ59161309A NZ591613A NZ 591613 A NZ591613 A NZ 591613A NZ 591613 A NZ591613 A NZ 591613A NZ 59161309 A NZ59161309 A NZ 59161309A NZ 591613 A NZ591613 A NZ 591613A
- Authority
- NZ
- New Zealand
- Prior art keywords
- thyroid cancer
- methods
- risk assessment
- polymorphic marker
- variants
- Prior art date
Links
- 208000024770 Thyroid neoplasm Diseases 0.000 title abstract 4
- 201000002510 thyroid cancer Diseases 0.000 title abstract 4
- 239000003550 marker Substances 0.000 title 1
- 238000012502 risk assessment Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/73—Expression systems using phage (lambda) regulatory sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/046—Thyroid disorders
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS8755 | 2008-08-12 | ||
| IS8791 | 2009-02-05 | ||
| PCT/IS2009/000010 WO2010018600A1 (en) | 2008-08-12 | 2009-08-12 | Genetic variants useful for risk assessment of thyroid cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ591613A true NZ591613A (en) | 2013-01-25 |
Family
ID=41217645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ591613A NZ591613A (en) | 2008-08-12 | 2009-08-12 | Polymorphic marker rs965513 for risk assessment of thyroid cancer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20110230366A1 (enExample) |
| EP (1) | EP2334820A1 (enExample) |
| JP (1) | JP2011530306A (enExample) |
| KR (1) | KR20110081807A (enExample) |
| CN (1) | CN102177252B (enExample) |
| AU (1) | AU2009280807A1 (enExample) |
| CA (1) | CA2733910A1 (enExample) |
| IL (1) | IL211177A0 (enExample) |
| NZ (1) | NZ591613A (enExample) |
| WO (1) | WO2010018600A1 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
| US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
| NZ593628A (en) * | 2008-11-26 | 2013-07-26 | Decode Genetics Ehf | Genetic variants useful for risk assessment of thyroid cancer using rs944289 |
| US8669057B2 (en) | 2009-05-07 | 2014-03-11 | Veracyte, Inc. | Methods and compositions for diagnosis of thyroid conditions |
| EP2686443A4 (en) * | 2011-03-17 | 2014-12-17 | Decode Genetics Ehf | GENETIC VARIANTS USEFUL IN ESTIMATING THE RISK OF THYROID CANCER |
| US8718950B2 (en) | 2011-07-08 | 2014-05-06 | The Medical College Of Wisconsin, Inc. | Methods and apparatus for identification of disease associated mutations |
| WO2013088457A1 (en) * | 2011-12-13 | 2013-06-20 | Decode Genetics Ehf | Genetic variants useful for risk assessment of thyroid cancer |
| US10260103B2 (en) | 2012-11-27 | 2019-04-16 | Pontificia Universidad Catolica De Chile | Compositions and methods for diagnosing thyroid tumors |
| US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
| KR102011383B1 (ko) * | 2014-10-31 | 2019-08-16 | 에스케이텔레콤 주식회사 | 갑상선암의 서브타입 분류용 조성물 |
| JP7356788B2 (ja) | 2014-11-05 | 2023-10-05 | ベラサイト インコーポレイテッド | 機械学習および高次元転写データを使用して経気管支生検における特発性肺線維症を診断するシステムおよび方法 |
| GB201504607D0 (en) * | 2015-03-18 | 2015-05-06 | Patia Biopharma S A De C V | Methods,tools and systems for the assessment,preventation,management and treatment selection for type 2 diabetes |
| CN106021992A (zh) * | 2015-03-27 | 2016-10-12 | 知源生信公司（美国硅谷） | 位置相关变体识别计算流水线 |
| US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
| KR102465122B1 (ko) | 2016-02-12 | 2022-11-09 | 리제너론 파마슈티칼스 인코포레이티드 | 비정상적인 핵형을 검출하기 위한 방법 및 시스템 |
| CN106636413B (zh) * | 2016-12-28 | 2019-07-16 | 常州市第二人民医院 | 一种用于诊断哮喘的分子标志物 |
| US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
| CN107194206A (zh) * | 2017-06-26 | 2017-09-22 | 思畅信息科技（上海）有限公司 | 一种基于大数据的染色体异常位点的筛选方法 |
| KR102081486B1 (ko) * | 2017-08-01 | 2020-02-25 | 사회복지법인 삼성생명공익재단 | Ahr 분류에 기반한 갑상선암 예후 예측 방법 및 시스템 |
| KR102097540B1 (ko) * | 2017-12-26 | 2020-04-07 | 주식회사 클리노믹스 | 질병 및 표현형 위험도 예측 장치 및 방법 |
| CN108315425B (zh) * | 2018-04-10 | 2021-08-06 | 广东省人民医院(广东省医学科学院) | 甲状腺癌转移相关基因检测用的pcr特异性引物、试剂盒及其使用方法 |
| US11216742B2 (en) | 2019-03-04 | 2022-01-04 | Iocurrents, Inc. | Data compression and communication using machine learning |
| KR102169699B1 (ko) * | 2019-12-27 | 2020-10-23 | 주식회사 클리노믹스 | 유전자 검사를 위한 맞춤형 유전자칩 및 이의 제작 방법 |
| CN114694836B (zh) * | 2020-12-30 | 2024-06-04 | 上海交通大学医学院附属瑞金医院 | 基于甲状腺癌淋巴结转移预测模型的评估系统 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US6054270A (en) * | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
| US5700637A (en) * | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5143854A (en) * | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) * | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5288644A (en) * | 1990-04-04 | 1994-02-22 | The Rockefeller University | Instrument and method for the sequencing of genome |
| US6287850B1 (en) * | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
| DE69527585T2 (de) * | 1994-06-08 | 2003-04-03 | Affymetrix, Inc. | Verfahren und Vorrichtung zum Verpacken von Chips |
| US6300063B1 (en) * | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
| WO1997045559A1 (en) * | 1996-05-29 | 1997-12-04 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
| US6429027B1 (en) * | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
| US20020077775A1 (en) * | 2000-05-25 | 2002-06-20 | Schork Nicholas J. | Methods of DNA marker-based genetic analysis using estimated haplotype frequencies and uses thereof |
| JP4729030B2 (ja) * | 2002-07-31 | 2011-07-20 | 株式会社東芝 | 塩基配列検出装置 |
| JP4994676B2 (ja) * | 2006-02-27 | 2012-08-08 | 富士通株式会社 | 遺伝子多型解析支援プログラム、該プログラムを記録した記録媒体、遺伝子多型解析支援装置、および遺伝子多型解析支援方法 |
| CN101608227A (zh) * | 2008-06-20 | 2009-12-23 | 上海主健生物工程有限公司 | 甲状腺癌遗传检测试剂盒 |
-
2009
- 2009-08-12 NZ NZ591613A patent/NZ591613A/xx not_active IP Right Cessation
- 2009-08-12 KR KR1020117005803A patent/KR20110081807A/ko not_active Ceased
- 2009-08-12 WO PCT/IS2009/000010 patent/WO2010018600A1/en not_active Ceased
- 2009-08-12 AU AU2009280807A patent/AU2009280807A1/en not_active Abandoned
- 2009-08-12 US US13/058,790 patent/US20110230366A1/en not_active Abandoned
- 2009-08-12 JP JP2011522616A patent/JP2011530306A/ja active Pending
- 2009-08-12 CA CA2733910A patent/CA2733910A1/en not_active Abandoned
- 2009-08-12 EP EP09787622A patent/EP2334820A1/en not_active Withdrawn
- 2009-08-12 CN CN200980139521.2A patent/CN102177252B/zh not_active Expired - Fee Related
-
2011
- 2011-02-10 IL IL211177A patent/IL211177A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011530306A (ja) | 2011-12-22 |
| IL211177A0 (en) | 2011-04-28 |
| CN102177252A (zh) | 2011-09-07 |
| CN102177252B (zh) | 2014-12-24 |
| CA2733910A1 (en) | 2010-02-18 |
| EP2334820A1 (en) | 2011-06-22 |
| US20110230366A1 (en) | 2011-09-22 |
| KR20110081807A (ko) | 2011-07-14 |
| WO2010018600A1 (en) | 2010-02-18 |
| AU2009280807A1 (en) | 2010-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ591613A (en) | Polymorphic marker rs965513 for risk assessment of thyroid cancer | |
| WO2010004591A3 (en) | Genetic variants for breast cancer risk assessment | |
| WO2010018601A3 (en) | Genetic variants predictive of cancer risk | |
| MX2009012722A (es) | Variantes geneticas sobre chr 5p12 y 10q26 como marcadores para el uso en la evaluacion del riesgo, diagnostico, pronostico y tratamiento del cancer de mama. | |
| HK1197085A1 (en) | Genetic variants for predicting risk of breast cancer | |
| EP2663656A1 (en) | Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment | |
| MX2009010439A (es) | Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. | |
| MX2009004522A (es) | Variantes de suceptibilidad a cancer en chr8q24.21. | |
| WO2010030365A3 (en) | Thyroid tumors identified | |
| NZ593628A (en) | Genetic variants useful for risk assessment of thyroid cancer using rs944289 | |
| GB2477705A (en) | Methods and compositions of molecular profiling for disease diagnostics | |
| IL200197A (en) | A method for assessing prostate cancer risk by determining genetic variants | |
| MX2014000292A (es) | Usos de inhibidores etiquetados hsp90. | |
| IN2012DN01403A (enExample) | ||
| MX356866B (es) | Biomarcadores p53. | |
| MX2009012531A (es) | Metodos y composiciones para identificar y tratar lupus. | |
| WO2008088860A3 (en) | Polymorphisms in the egfr pathway as markers for cancer treatment | |
| MX2015000008A (es) | Uso de marcadores en el diagnostico y tratamiento de cancer de prostata. | |
| MX2007013727A (es) | Caracterizacion de cancer de prostata. | |
| WO2010120143A3 (ko) | 간암 예후 마커 | |
| WO2009086215A3 (en) | Pathway analysis of cell culture phenotypes and uses thereof | |
| WO2008132763A3 (en) | Genetic variants useful for risk assessment of coronary artery disease and myocardial infarction | |
| ZA200710910B (en) | Methods for the assessment of risk of developing lung cancer using analysis of genetic polymorphisms | |
| WO2009085196A8 (en) | Methods and compositions for correlating genetic markers with prostate cancer risk | |
| MX2009004382A (es) | Variaciones geneticas asociadas con tumores. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AVOD | Application void | ||
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 12 AUG 2016 BY LEA SKYLLERSTEDT Effective date: 20130718 |
|
| LAPS | Patent lapsed |